| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E-mail contact: jia.chen@mssm.edu
Choline is an essential nutrient required for methyl group metabolism, but its role in carcinogenesis and tumor progression is not well understood. By utilizing a population-based study of 1508 cases and 1556 controls, we investigated the associations of dietary intake of choline and two related micronutrients, methionine and betaine, and risk of breast cancer. The highest quintile of choline consumption was associated with a lower risk of breast cancer [odds ratio (OR): 0.76; 95% confidence interval (CI): 0.58–1.00] compared with the lowest quintile. Two putatively functional single nucleotide polymorphisms of choline-metabolizing genes, PEMT -774G>C (rs12325817) and CHDH +432G>T (rs12676), were also found be related to breast cancer risk. Compared with the PEMT GG genotype, the variant CC genotype was associated with an increased risk of breast cancer (OR: 1.30; 95% CI: 1.01–1.67). The CHDH minor T allele was also associated with an increased risk (OR: 1.19; 95% CI: 1.00–1.41) compared with the major G allele. The BHMT rs3733890 polymorphism was also examined but was found not to be associated with breast cancer risk. We observed a significant interaction between dietary betaine intake and the PEMT rs7926 polymorphism (Pinteraction=0.04). Our findings suggest that choline metabolism may play an important role in breast cancer etiology.—Xu, X., Gammon, M. D., Zeisel, S. H., Lee, Y. L., Wetmur, J. G., Teitelbaum, S. L., Bradshaw, P. T., Neugut, A. I., Santella, R. M., Chen, J. Choline metabolism and risk of breast cancer in a population-based study.
This article has been cited by other articles:
|
|
 |
|
  J. E. Lee, E. Giovannucci, C. S. Fuchs, W. C. Willett, S. H. Zeisel, and E. Cho Choline and Betaine Intake and the Risk of Colorectal Cancer in Men Cancer Epidemiol. Biomarkers Prev., March 1, 2010; 19(3): 884 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, M. D. Gammon, S. H. Zeisel, P. T. Bradshaw, J. G. Wetmur, S. L. Teitelbaum, A. I. Neugut, R. M. Santella, and J. Chen High intakes of choline and betaine reduce breast cancer mortality in a population-based study FASEB J, November 1, 2009; 23(11): 4022 - 4028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-D. Yu, G.-H. Di, L. Fan, J. Wu, Z. Hu, Z.-Z. Shen, W. Huang, and Z.-M. Shao A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer FASEB J, July 1, 2009; 23(7): 2274 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Johansson, B. Van Guelpen, S. E. Vollset, J. Hultdin, A. Bergh, T. Key, O. Midttun, G. Hallmans, P. M. Ueland, and P. Stattin One-Carbon Metabolism and Prostate Cancer Risk: Prospective Investigation of Seven Circulating B Vitamins and Metabolites Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1538 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Kovacheva, J. M. Davison, T. J. Mellott, A. E. Rogers, S. Yang, M. J. O'Brien, and J. K. Blusztajn Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival FASEB J, April 1, 2009; 23(4): 1054 - 1063. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
